Synapse

← Expert Review of Precision Medicine and Drug Development

Papers in Expert Review of Precision Medicine and Drug Development

Page 4 · newest first

  1. Precision medicine to change the landscape of cardiovascular drug developmentExpert Review of Precision Medicine and Drug Development · 2017
  2. The fungal meningitis outbreak five years later: what have we learned about Exserohilum rostratum ?Expert Review of Precision Medicine and Drug Development · 2017
  3. The role of artificial intelligence in precision medicineExpert Review of Precision Medicine and Drug Development · 2017
  4. Prospects for precision therapy of bladder urothelial carcinomaExpert Review of Precision Medicine and Drug Development · 2017
  5. Checkpoint inhibitors and the risk of infectionExpert Review of Precision Medicine and Drug Development · 2017
  6. Towards a personalized assessment of pancreatic function in diabetesExpert Review of Precision Medicine and Drug Development · 2017
  7. AGS-003 combined with sunitinib for the precision treatment of metastatic renal cell carcinomaExpert Review of Precision Medicine and Drug Development · 2017
  8. Harnessing the potential of CRISPR-Cas9 to advance the study of human fungal pathogensExpert Review of Precision Medicine and Drug Development · 2017
  9. Tissue-based biomarkers in prostate cancerExpert Review of Precision Medicine and Drug Development · 2017
  10. Molecular stratification of colorectal cancer populations and its use in directing precision medicineExpert Review of Precision Medicine and Drug Development · 2017
  11. Obstructive sleep apnea: in search of precisionExpert Review of Precision Medicine and Drug Development · 2017
  12. Statin therapy: time for a precision medicine approach?Expert Review of Precision Medicine and Drug Development · 2017
  13. Structural brain network architecture and personalized medicine in epilepsyExpert Review of Precision Medicine and Drug Development · 2017
  14. Precision medicine in gastric cancer: where are we now?Expert Review of Precision Medicine and Drug Development · 2017
  15. Coincidence versus consequence: opportunities in multi-morbidity research and inflammation as a pervasive featureExpert Review of Precision Medicine and Drug Development · 2017
  16. The role of the MET/AXL pathway as a new target for multikinase inhibitors in renal cell carcinomaExpert Review of Precision Medicine and Drug Development · 2017
  17. Opioid-induced respiratory depression: the role of geneticsExpert Review of Precision Medicine and Drug Development · 2017
  18. Applications of digital PCR in precision medicineExpert Review of Precision Medicine and Drug Development · 2017
  19. Preemptive sequencing in the genomic medicine eraExpert Review of Precision Medicine and Drug Development · 2017
  20. Use of precision methods to accelerate drug development in oncologyExpert Review of Precision Medicine and Drug Development · 2017
  21. Cognitive remediation of executive functioning in youth with neuropsychiatric conditions: current knowledge on feasibility, effectiveness, and personalizationExpert Review of Precision Medicine and Drug Development · 2017
  22. Precision drug development in ROS1-positive lung cancerExpert Review of Precision Medicine and Drug Development · 2017
  23. Targeting the immune system in glioblastomaExpert Review of Precision Medicine and Drug Development · 2017
  24. Could autologous hematopoietic stem cell transplantation be considered a second-line treatment option in relapsing-remitting multiple sclerosis? A critical editorialExpert Review of Precision Medicine and Drug Development · 2017
  25. Immunotherapy in genitourinary cancers: where are we going?Expert Review of Precision Medicine and Drug Development · 2017
  26. The role of epigenomics in personalized medicineExpert Review of Precision Medicine and Drug Development · 2017
  27. Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetesExpert Review of Precision Medicine and Drug Development · 2017
  28. Using genetics to predict patient response to platinum-based chemotherapyExpert Review of Precision Medicine and Drug Development · 2017
  29. Genomic-based diagnosis of arrhythmia disease in a personalized medicine eraExpert Review of Precision Medicine and Drug Development · 2016
  30. The role of metabolomics in precision medicineExpert Review of Precision Medicine and Drug Development · 2016
  31. Personalized management of asthma exacerbations: lessons from genetic studiesExpert Review of Precision Medicine and Drug Development · 2016
  32. Precision management of localized prostate cancerExpert Review of Precision Medicine and Drug Development · 2016
  33. The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymesExpert Review of Precision Medicine and Drug Development · 2016
  34. Precision medicine in glioblastoma therapyExpert Review of Precision Medicine and Drug Development · 2016
  35. MicroRNA-profiles in lung adenocarcinomasExpert Review of Precision Medicine and Drug Development · 2016
  36. The role of precision medicine for the treatment of metastatic renal cell carcinomaExpert Review of Precision Medicine and Drug Development · 2016
  37. A review of drugs in development for the personalized treatment of head and neck squamous cell carcinomaExpert Review of Precision Medicine and Drug Development · 2016
  38. Coronary artery disease genetic risk awareness motivates heart health behaviors in the Coriell Personalized Medicine CollaborativeExpert Review of Precision Medicine and Drug Development · 2016
  39. Precise medical decision making in geriatric anti-depressant therapyExpert Review of Precision Medicine and Drug Development · 2016
  40. Personalized therapy in multiple sclerosis: state of art and future perspectivesExpert Review of Precision Medicine and Drug Development · 2016
  41. Clinical implementation of genomic medicine: the importance of global collaborationExpert Review of Precision Medicine and Drug Development · 2016
  42. Technological advances in precision medicine and drug developmentExpert Review of Precision Medicine and Drug Development · 2016
  43. Clinical impact of tumoral angiogenesis on renal cell carcinoma management: where do we stand?Expert Review of Precision Medicine and Drug Development · 2016
  44. Regulatory barriers to the advancement of precision medicineExpert Review of Precision Medicine and Drug Development · 2016
  45. Use of big data in drug development for precision medicineExpert Review of Precision Medicine and Drug Development · 2016
  46. Personalizing fluoropyrimidine administration in colorectal cancer patientsExpert Review of Precision Medicine and Drug Development · 2016
  47. Personalized immunotherapy in colorectal cancerExpert Review of Precision Medicine and Drug Development · 2016
  48. Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutationExpert Review of Precision Medicine and Drug Development · 2016
  49. Vitamin K and bone metabolism: the myth and the truthExpert Review of Precision Medicine and Drug Development · 2016
  50. Radiomics: a new application from established techniquesExpert Review of Precision Medicine and Drug Development · 2016